Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.
Brandywine Realty Trust (NYSE: BDN) shares increased 2.49 percent to close at $12.77 a share Friday. The stock traded between $12.73 and $13.02 on volume of 2.27 million shares traded. Analysts at Stifel have recently upgraded the company’s rating to "buy" from "hold". Shares of Brandywine Realty Trust have gained approximately 4.7 percent year-to-date.
Find out more about Brandywine Realty Trust including full access to the free equity report at:
Kythera Biopharmaceuticals Inc. (NASDAQ: KYTH) shares increased 2.19 percent to close at $28.50 a share Friday. The stock traded between $27.91 and $29.95 on volume of 136,494 shares traded. Analysts at Cowen have recently initiated coverage on the company with an "outperform" rating and a price target of $50.00. Shares of Kythera Biopharmaceuticals have fallen approximately 6.0 percent year-to-date.
Find out more about Kythera Biopharmaceuticals including full access to the free equity report at:
Potlatch Corporation (NASDAQ: PCH) shares increased 0.34 percent to close at $38.48 a share Friday. The stock traded between $38.01 and $38.968 on volume of 302,997 shares traded. Analysts at RBC Capital have recently initiated coverage on the company with a "sector perform" rating and a price target of $42.00.
Find out more about Potlatch including full access to the free equity report at:
Koninklijke Philips NV (NYSE: PHG) shares increased 1.63 percent to close at $32.96 a share Friday. The stock traded between $32.29 and $33.03 on volume of 1.49 million shares traded. Analysts at Citigroup have recently upgraded the company’s rating to "buy" from "sell". Shares of Koninklijke Philips have gained approximately 24.0 percent year-to-date.
Find out more about Koninklijke Philips including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing
Leave a comment...